Progranulin-Boosting Drug Moves into Phase 2 for Frontotemporal Dementia

A drug being tested for cases of FTD with a progranulin mutation moves into phase 2. Read the article here.
By Category
Our Newsletters
Stay Informed

Sign up now and stay on top of the latest with our newsletter, event alerts, and more…